Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
14.10
Ask:
16.90
Spread: 2.80 (19.858%)
Market Cap: £12.51m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Annual Financial Report

8 Apr 2016 14:27

LMS CAPITAL PLC - Annual Financial Report

LMS CAPITAL PLC - Annual Financial Report

PR Newswire

London, April 8

8 April 2016

LMS Capital plc

2015 Annual Report and

Notice of 2016 Annual General Meeting

LMS Capital plc ("LMS Capital" or "the Company") has today published its 2015 Annual Report and Notice of its 2016 Annual General Meeting. These documents are available in the Investor Relations section on the Company's website, www.lmscapital.com. This follows the release on 18 March 2016 of the Company's Preliminary Results Announcement for the year ended 31 December 2015.

In compliance with Rule 9.6.1 of the Listing Rules, the Company has submitted to the UK Listing Authority, via the National Storage Mechanism, copies of the LMS Capital 2015 Annual Report, the Notice of its 2016 Annual General Meeting and a sample of a Form of Proxy for use at that meeting. The LMS Capital 2015 Annual Report will be filed with the Registrar of Companies in due course and copies can be obtained from the Company Secretary, LMS Capital plc, 100 George Street, London W1U 8NU. The Annual General Meeting will be held at 12.00 pm on Thursday 19 May 2016.

The Disclosure and Transparency Rules (DTR 6.3.5(2)) require certain information to be disclosed upon publication of an Annual Report. Accordingly, the following disclosures are made in the Appendices below. References to page numbers and notes to the accounts made in these Appendices refer to page numbers and notes to the accounts in the Company’s 2015 Annual Report.

For further information, please contact:

LMS Capital plc 020 7935 3555

Nick Friedlos, Director

Tony Sweet, Chief Financial Officer

About LMS Capital plc

LMS Capital is an investment company which, following a general meeting on 30 November 2011, is undertaking a realisation strategy with the aim of achieving a balance between an efficient return of cash to shareholders and optimising the value of the Company's investments. Its investment portfolio consists of small to medium sized companies across a range of sectors.

Appendix A - Statement of Directors' responsibilities

The 2015 Annual Report includes on page 37 a responsibility statement dated 18 March 2016, the date of approval of the 2015 Annual Report, and signed for and on behalf of the Board by Nicholas Friedlos and Antony Sweet. The following is extracted from that statement:

We confirm that to the best of our knowledge:

· the financial statements, prepared in accordance with IFRSs as adopted by the EU, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole;

· the Annual Report and financial statements, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's performance, business model and strategy; and

· the Strategic report includes a fair review of the development and performance of the business and the position of the issuer and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face.

Appendix B - Related party transactions

The following is extracted in a full and unedited form from note 19 on page 70 of the Company's Annual Report:

With effect from January 2011 the Company entered into a lease agreement with Derwent London plc in respect of the premises comprising its head office and registered office. Under the terms of the lease the Company pays an annual rent of £289,000 to Derwent London plc plus certain service charges. Robert Rayne is Chairman of Derwent London plc.

Under an arrangement with SQP Limited the Company pays fees of £60,000 per annum for the provision of services by Robert Rayne.

Compensation arrangements for Directors and key management are set out in the Remuneration Committee report on pages 24 to 27.

In connection with the tender offer in May 2014, the Company received an irrevocable undertaking from Withers Trust Corporation Limited (the “Undertaking”). The purpose of the Undertaking was a contingency measure to ensure that members of the extended Rayne family and associated trusts (the “Concert Party”) would in aggregate tender sufficient shares so that the Concert Party’s percentage interest in the ordinary shares of the Company would not increase as a consequence of the tender offer and consequently avoid any requirement under the City Code on Takeovers and Mergers for the Concert Party to make an offer for all the issued shares of the Company which they did not own.

The Undertaking was classified as a related party transaction under the Listing Rules and was therefore subject to approval by non-Concert Party shareholders at the general meeting to approve the May 2014 tender offer – which approval was duly given. For the purposes of this classification the deemed value of the consideration for the Undertaking was £8.4 million. The results of the tender offer in May 2014 required 45,764 extra shares to be tendered under the terms of the Undertaking.

No fee was payable by the Company in connection with the Undertaking.

There was no such undertaking in connection with the tender offer in November 2015.

Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.